Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
7,442,329
-
Share change
-
+931,232
-
Total reported value
-
$66,697,000
-
Put/Call ratio
-
91%
-
Price per share
-
$8.97
-
Number of holders
-
45
-
Value change
-
+$8,406,975
-
Number of buys
-
28
-
Number of sells
-
11
Institutional Holders of TONIX PHARMACEUTICALS HLDG C - COM NEW (TNXP) as of Q2 2015
As of 30 Jun 2015,
TONIX PHARMACEUTICALS HLDG C - COM NEW (TNXP) was held by
45 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,442,329 shares.
The largest 10 holders included
DEERFIELD MANAGEMENT CO, KINGDON CAPITAL MANAGEMENT, L.L.C., Broadfin Capital, LLC, venBio Select Advisor LLC, MILLENNIUM MANAGEMENT LLC, FRANKLIN RESOURCES INC, VANGUARD GROUP INC, BLUESTEIN R H & CO, Lombard Odier Asset Management (USA) Corp, and MORGAN STANLEY.
This page lists
45
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.